Testosterone MDL Judge: Reference Listed Drug Claims Are Preempted
CHICAGO — Although two generic testosterone replacement therapy products are reference listed drugs (RLDs), their manufacturers still cannot add new warnings and claims by plaintiffs in a multidistrict litigation are preempted...To view the full article, register now.
Already a subscriber? Click here to view full article